Cargando…

In silico drug repositioning using deep learning and comprehensive similarity measures

BACKGROUND: Drug repositioning, meanings finding new uses for existing drugs, which can accelerate the processing of new drugs research and development. Various computational methods have been presented to predict novel drug–disease associations for drug repositioning based on similarity measures am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Hai-Cheng, You, Zhu-Hong, Wang, Lei, Su, Xiao-Rui, Zhou, Xi, Jiang, Tong-Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170943/ https://www.ncbi.nlm.nih.gov/pubmed/34074242 http://dx.doi.org/10.1186/s12859-020-03882-y

Ejemplares similares

Guiding Drug Repositioning for Cancers Based on Drug Similarity Networks
por: Qin, Shimei, et al.
Publicado: (2023)

An in silico drug repositioning workflow for host-based antivirals
por: Li, Zexu, et al.
Publicado: (2021)

MeSHDD: Literature-based drug-drug similarity for drug repositioning
por: Brown, Adam S, et al.
Publicado: (2017)

A Review of Current In Silico Methods for Repositioning Drugs and Chemical Compounds
por: He, Binsheng, et al.
Publicado: (2021)

The assessment of efficient representation of drug features using deep learning for drug repositioning
por: Moridi, Mahroo, et al.
Publicado: (2019)

β-Secretase-1: In Silico Drug Reposition for Alzheimer’s Disease
por: Galeana-Ascencio, Roberto A., et al.
Publicado: (2023)

Old drug repositioning and new drug discovery through similarity learning from drug-target joint feature spaces
por: Zheng, Yi, et al.
Publicado: (2019)

In silico drug repositioning based on integrated drug targets and canonical correlation analysis
por: Chen, Hailin, et al.
Publicado: (2022)

In silico drug repositioning based on the integration of chemical, genomic and pharmacological spaces
por: Chen, Hailin, et al.
Publicado: (2021)

Topological network measures for drug repositioning
por: Badkas, Apurva, et al.
Publicado: (2020)

Prediction of Drug-Target Interactions for Drug Repositioning Only Based on Genomic Expression Similarity
por: Wang, Kejian, et al.
Publicado: (2013)

Drug repositioning for SARS-CoV-2 by Gaussian kernel similarity bilinear matrix factorization
por: Wang, Yibai, et al.
Publicado: (2022)

Learning Opportunities for Drug Repositioning via GWAS and PheWAS Findings
por: Yin, Wen, et al.
Publicado: (2018)

DOTA: Deep Learning Optimal Transport Approach to Advance Drug Repositioning for Alzheimer’s Disease
por: Chyr, Jacqueline, et al.
Publicado: (2022)

In silico repositioning of approved drugs against Schistosoma mansoni energy metabolism targets
por: Calixto, Nicole Melo, et al.
Publicado: (2018)

Correction: Prediction of Drug-Target Interactions for Drug Repositioning Only Based on Genomic Expression Similarity
por: Wang, Kejian, et al.
Publicado: (2013)

NFFinder: an online bioinformatics tool for searching similar transcriptomics experiments in the context of drug repositioning
por: Setoain, Javier, et al.
Publicado: (2015)

A Large-Scale Gene Expression Intensity-Based Similarity Metric for Drug Repositioning
por: Huang, Chen-Tsung, et al.
Publicado: (2018)

A novel in silico scaffold-hopping method for drug repositioning in rare and intractable diseases
por: Tanabe, Mao, et al.
Publicado: (2023)

Thiopurine Drugs Repositioned as Tyrosinase Inhibitors
por: Choi, Joonhyeok, et al.
Publicado: (2017)

Unraveling Gene Fusions for Drug Repositioning in High-Risk Neuroblastoma
por: Liu, Zhichao, et al.
Publicado: (2021)

Comprehensive network medicine-based drug repositioning via integration of therapeutic efficacy and side effects
por: Paci, Paola, et al.
Publicado: (2022)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

Novel candidate drugs in anti-tumor necrosis factor refractory Crohn’s diseases: in silico study for drug repositioning
por: Kwak, Min Seob, et al.
Publicado: (2020)

ACP-DL: A Deep Learning Long Short-Term Memory Model to Predict Anticancer Peptides Using High-Efficiency Feature Representation
por: Yi, Hai-Cheng, et al.
Publicado: (2019)

Drug repositioning based on similarity constrained probabilistic matrix factorization: COVID-19 as a case study
por: Meng, Yajie, et al.
Publicado: (2021)

Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study
por: Ramírez-Salinas, Gema Lizbeth, et al.
Publicado: (2020)

Repositioning of Antiparasitic Drugs for Tumor Treatment
por: Li, Yan-Qi, et al.
Publicado: (2021)

A drug repositioning algorithm based on a deep autoencoder and adaptive fusion
por: Chen, Peng, et al.
Publicado: (2021)

A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19)
por: Rameshrad, Maryam, et al.
Publicado: (2020)

Drug repositioning for personalized medicine
por: Li, Yvonne Y, et al.
Publicado: (2012)

Network mirroring for drug repositioning
por: Park, Sunghong, et al.
Publicado: (2017)

Drug Repositioning for COVID-19
por: Benavides-Cordoba, Vicente
Publicado: (2020)

GREP: genome for REPositioning drugs
por: Sakaue, Saori, et al.
Publicado: (2019)

Transcriptome-Guided Drug Repositioning
por: Arakelyan, Arsen, et al.
Publicado: (2019)

Drug Repositioning in Friedreich Ataxia
por: Rufini, Alessandra, et al.
Publicado: (2022)

Drug Repositioning for Diabetes Based on 'Omics' Data Mining
por: Zhang, Ming, et al.
Publicado: (2015)

Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans—In Silico, In Vitro and In Vivo Approaches
por: Santos, André L. S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jrkf1vkbvlm1ib2os7ln7rgvhg